Experts gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.
Back
Cellular Currents in Collaboration With ASTCT Talks
Cellular Currents, in collaboration with the American Society of Transplant and Cellular Therapies, is dedicated to the fast-moving world of cell and gene therapy. Each episode brings listeners inside the science and strategy shaping this rapidly evolving field—whether it's a first-in-class CAR T-cell therapy, an emerging gene editing platform, or updated consensus recommendations for managing toxicity. Cellular Currents keeps pharmacists and the broader oncology care team current on what's changing—and why it matters at the bedside.
Cellular Currents in Collaboration With ASTCT Talks
Episodes
All
All
Updated ASTCT infectious disease guidelines reshape approaches to prophylaxis, treatment thresholds, and drug-drug interactions in opportunistic infections.
Pharmacists unpack CAR T-cell therapy in acute lymphoblastic leukemia, spotlighting obecabtagene autoleucel data and toxicity tips.
Discover the vital role of oncology pharmacists in cancer care, exploring their daily challenges, responsibilities, and impact on patient outcomes.
Oncology pharmacists unpack cGVHD care, highlighting axatilimab’s mechanism, safety monitoring, and team-based strategies to optimize outcomes.
Oncology pharmacists advance multiple myeloma care with BCMA bispecifics and CAR T-cell therapy, improving safety, logistics, and outcomes for American Pharmacist Month.
Advertisement
Advertisement
Trending on Pharmacy Times
1
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
2
New CKD Outcome Set Tells Pharmacists What to Measure
3
GLP-1s and the HCM–Sleep Apnea–Obesity Connection
4
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
5